These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8223835)

  • 41. Paracetamol test: modification by renal function, urine flow and pH.
    Kietzmann D; Bock KW; Krähmer B; Kettler D; Bircher J
    Eur J Clin Pharmacol; 1990; 39(3):245-51. PubMed ID: 2257860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toxicological studies in a Distalgesic addict.
    Roberts I; Flanagan RJ; Strang J; Prescott LF
    Hum Toxicol; 1986 May; 5(3):207-10. PubMed ID: 3710498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanistic and Quantitative Understanding of Pharmacokinetics in Zebrafish Larvae through Nanoscale Blood Sampling and Metabolite Modeling of Paracetamol.
    Van Wijk RC; Krekels EHJ; Kantae V; Ordas A; Kreling T; Harms AC; Hankemeier T; Spaink HP; van der Graaf PH
    J Pharmacol Exp Ther; 2019 Oct; 371(1):15-24. PubMed ID: 31371482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new method of post-dialysis blood urea sampling: the 'stop dialysate flow' method.
    Geddes CC; Traynor J; Walbaum D; Fox JG; Mactier RA
    Nephrol Dial Transplant; 2000 Apr; 15(4):517-23. PubMed ID: 10727547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
    Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation and identification of paracetamol metabolites.
    Andrews RS; Bond CC; Burnett J; Saunders A; Watson K
    J Int Med Res; 1976; 4(4 Suppl):34-9. PubMed ID: 1026559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of intravenous paracetamol in children and adolescents under major surgery.
    Würthwein G; Koling S; Reich A; Hempel G; Schulze-Westhoff P; Pinheiro PV; Boos J
    Eur J Clin Pharmacol; 2005 Feb; 60(12):883-8. PubMed ID: 15662506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute effects of paracetamol on prostaglandin synthesis and renal function in normal man and in patients with renal failure.
    Berg KJ; Djøseland O; Gjellan A; Hundal O; Knudsen ER; Rugstad HE; Rønneberg E
    Clin Nephrol; 1990 Dec; 34(6):255-62. PubMed ID: 2073768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The estimation of paracetamol and its major metabolites in both plasma and urine by a single high-performance liquid chromatography assay.
    Lau GS; Critchley JA
    J Pharm Biomed Anal; 1994 Dec; 12(12):1563-72. PubMed ID: 7696381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolism by conjugation appears to confer resistance to paracetamol (acetaminophen) hepatotoxicity in the cynomolgus monkey.
    Yu H; Barrass N; Gales S; Lenz E; Parry T; Powell H; Thurman D; Hutchison M; Wilson ID; Bi L; Qiao J; Qin Q; Ren J
    Xenobiotica; 2015 Mar; 45(3):270-7. PubMed ID: 25335570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of propranolol on paracetamol metabolism in man.
    Baraka OZ; Truman CA; Ford JM; Roberts CJ
    Br J Clin Pharmacol; 1990 Feb; 29(2):261-4. PubMed ID: 2306420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigating paracetamol pharmacokinetics using venous and capillary blood and saliva sampling.
    Rittau AM; McLachlan AJ
    J Pharm Pharmacol; 2012 May; 64(5):705-11. PubMed ID: 22471366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolism of low-dose paracetamol in patients with rheumatoid arthritis.
    Bradley H; Waring RH; Emery P; Arthur V
    Xenobiotica; 1991 May; 21(5):689-93. PubMed ID: 1949902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Automated liquid chromatographic method for the determination of paracetamol and six metabolites in human urine.
    Ladds G; Wilson K; Burnett D
    J Chromatogr; 1987 Mar; 414(2):355-64. PubMed ID: 3571403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype.
    Veronese ME; McLean S
    Eur J Clin Pharmacol; 1991; 40(6):547-52. PubMed ID: 1884734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The comparative pharmacokinetics of modified-release and immediate-release paracetamol in a simulated overdose model.
    Chiew A; Day P; Salonikas C; Naidoo D; Graudins A; Thomas R
    Emerg Med Australas; 2010 Dec; 22(6):548-55. PubMed ID: 21143403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of ciprofloxacin tablets in renal failure; influence of haemodialysis.
    Singlas E; Taburet AM; Landru I; Albin H; Ryckelinck JP
    Eur J Clin Pharmacol; 1987; 31(5):589-93. PubMed ID: 3830244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Passage of paracetamol into breast milk and its subsequent metabolism by the neonate.
    Notarianni LJ; Oldham HG; Bennett PN
    Br J Clin Pharmacol; 1987 Jul; 24(1):63-7. PubMed ID: 3620287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single dose primaquine has no effect on paracetamol clearance.
    Back DJ; Tjia JF
    Eur J Clin Pharmacol; 1987; 32(2):203-5. PubMed ID: 3582486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absorption of effervescent paracetamol tablets relative to ordinary paracetamol tablets in healthy volunteers.
    Rygnestad T; Zahlsen K; Samdal FA
    Eur J Clin Pharmacol; 2000 May; 56(2):141-3. PubMed ID: 10877008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.